NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Multiprofile Hospital for Active Treatment Serdika EOOD, Sofia

Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz, Nyíregyháza

Tolna Megyei Balassa Janos Korhaz, Szekszárd

Pecsi Tudomanyegyetem, Pécs

Complex Oncology Center - Shumen EOOD, Shumen

Icahn School of Medicine at Mount Sinai, New York

University of North Carolina at Chapel Hill, Chapel Hill

Barbara Ann Karmanos Cancer Center, Detroit

Northwestern University, Chicago

The University of Oklahoma Health Sciences Center, Oklahoma City

Intermountain Precision Genomics, Billings

Cedars Sinai Medical Center, Los Angeles

Oncology Center Sfantul Nectarie, Craiova

Prof Dr I Chiricuta Institute of Oncology, Cluj-Napoca

Euroclinic Oncology Center SRL, Iași

Institutul Regional de Oncologie Iasi, Iași

Winship Cancer Institute, Emory University, Atlanta

Massachusetts General Hospital, Boston

University of Texas Southwestern Medical Center, Dallas

Coltea Clinical Hospital, Bucharest